Download PDF
Handchir Mikrochir Plast Chir 2016; 48(03): 127-135
DOI: 10.1055/s-0042-104504
Übersichtsarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Die perioperative Handhabung von Antikoagulantien in der elektiven Handchirurgie – eine Literaturübersicht

Perioperative Anticoagulation in Elective Hand Surgery: A Literature Review
C. Ahrens
1   Vulpius Klinik, Abteilung für Handchirurgie, Bad Rappenau
,
F. Unglaub
1   Vulpius Klinik, Abteilung für Handchirurgie, Bad Rappenau
4   Medizinische Fakultät Mannheim der Universität Heidelberg
,
B. Hohendorff
2   Abteilung für Hand-, Ästhetische und Plastische Chirurgie, Elbe Klinikum Stade, Stade
,
L. P. Müller
3   Klinik und Poliklinik für Orthopädie und Unfallchirurgie, Universitätsklinik Köln, Köln
,
C. K. Spies
1   Vulpius Klinik, Abteilung für Handchirurgie, Bad Rappenau
› Author Affiliations
Further Information

Publication History

eingereicht 21 July 2015

akzeptiert 06 March 2016

Publication Date:
23 May 2016 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Die vorliegende Arbeit beschreibt auf der Grundlage einer aktuellen Literaturrecherche mögliche Handlungspfade für die perioperative Handhabung von Antikoagulantien in der elektiven Handchirurgie.

Abstract

This review highlights pathways regarding the handling of anticoagulation in elective hand surgery based on current literature.

Schlüsselwörter

Antikoagulantien - elektive Handchirurgie

Key words

anticoagulants - elective hand surgery
 

  • Literatur

  • 1 Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg 2010; 15: 109-113
    CrossrefPubMedGoogle Scholar
  • 2 Bogunovic L, Gelberman RH, Goldfarb CA et al. The impact of antiplatelet medication on hand and wrist surgery. J Hand Surg Am 2013; 38: 1063-1070
    CrossrefPubMedGoogle Scholar
  • 3 Jivan S, Southern S, Majumder S. Re: the effects of aspirin in patients undergoing carpal tunnel decompression. J Hand Surg Eur Vol 2008; 33: 813-814
    CrossrefPubMedGoogle Scholar
  • 4 Naito K, Lequint T, Zemirline A et al. Should we stop oral anticoagulants in the surgical treatment of carpal tunnel syndrome?. Hand 2012; 7: 267-270
    CrossrefPubMedGoogle Scholar
  • 5 Smit A, Hooper G. Elective hand surgery in patients taking warfarin. J Hand Surg Eur Vol 2004; 29: 204-205
    CrossrefPubMedGoogle Scholar
  • 6 Wallace DL, Latimer MD, Belcher HJ. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Eur Vol 2004; 29: 203-205
    CrossrefPubMedGoogle Scholar
  • 7 Lindsley RC. Perioperative management of systemic oral anticoagulants in patients having outpatient hand surgery. J Hand Surg Am 2008; 33: 1205-1207
    CrossrefPubMedGoogle Scholar
  • 8 Bogunovic L, Gelberman RH, Goldfarb CA et al. The Impact of Uninterrupted Warfarin on Hand and Wrist Surgery. J Hand Surg Am 2015; 40: 2133-2140
    CrossrefPubMedGoogle Scholar
  • 9 Schellong SM, Haas S, Siebenlist S. Überbrückung Pausieren und Wechsel von Antikoagulantien in der Unfallchirurgie. Unfallchirurg 2010; 113: 901-907
    CrossrefPubMedGoogle Scholar
  • 10 Spyropoulos AC, Douketis JD, Gerotziafas G et al. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. JTH 2012; 10: 692-694
    PubMedGoogle Scholar
  • 11 Eisele R, Melzer N, Bramlage P. Perioperatives Gerinnungsmanagement bei oraler Antikoagulation. Chirurg 2014; 85: 513-519
    CrossrefPubMedGoogle Scholar
  • 12 European Heart Rhythm Association (EHRA), European Association for Cardio-Thoracic Surgery (EACTS). Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). EHJ 2010; 31: 2369-2429
    CrossrefPubMedGoogle Scholar
  • 13 Bridge Study Investigators. Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure?. Circulation 2012; 125: e496-e498
    CrossrefPubMedGoogle Scholar
  • 14 Bauersachs R, Schellong S, Haas S et al. Überbrückung der oralen Antikoagulation bei interventionellen Eingriffen. Dtsch Ärztebl Int 2007; 104: 1237-1244
    PubMedGoogle Scholar
  • 15 Tiede A. Perioperatives hämostaseologisches Management. Chirurg 2007; 78: 69-79
    CrossrefPubMedGoogle Scholar
  • 16 Koscielny J, von Tempelhoff GF, Ziemer S et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 155-166
    CrossrefPubMedGoogle Scholar
  • 17 Tafur AJ, McBane R, Wysokinski WE et al. Predictors of major bleeding in peri-procedural anticoagulation management. JTH 10: 261-267
    PubMedGoogle Scholar
  • 18 Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Int Med 2004; 164: 1319-1326
    CrossrefPubMedGoogle Scholar
  • 19 Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3-15
    CrossrefPubMedGoogle Scholar
  • 20 Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109-1116
    CrossrefPubMedGoogle Scholar
  • 21 Jernberg T, Payne CD, Winters KJ et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. EHJ 2006; 27: 1166-1173
    PubMedGoogle Scholar
  • 22 Smith MS, Muir H, Hall R. Perioperative management of drug therapy, clinical considerations. Drugs 1996; 51: 238-259
    CrossrefPubMedGoogle Scholar
  • 23 Vogel Kahmann I, Ruppen W, Lurati Buse G et al. Langzeitmedikation und perioperatives Management. Internist 2011; 52: 89-98
    CrossrefPubMedGoogle Scholar
  • 24 Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. EHJ 2006; 27: 2667-2674
    CrossrefPubMedGoogle Scholar
  • 25 Burger W, Chemnitius JM, Kneissl GD et al. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Int Med 2005; 257: 399-414
    CrossrefPubMedGoogle Scholar
  • 26 Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-328
    CrossrefPubMedGoogle Scholar
  • 27 Mangano DT. Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-1317
    CrossrefPubMedGoogle Scholar
  • 28 Nuttall GA, Brown MJ, Stombaugh JW et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109: 588-595
    CrossrefPubMedGoogle Scholar
  • 29 Rabbitts JA, Nuttall GA, Brown MJ et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596-604
    CrossrefPubMedGoogle Scholar
  • 30 Kozek-Langenecker SA. Lokoregionalanästhesie und Blutgerinnung. Behandlung mit Thrombozytenfunktionshemmern. Anaesthesist 2003; 52: 549-563
    CrossrefPubMedGoogle Scholar
  • 31 Lepper W, Kelm M. Perioperative Therapie mit Thrombozytenaggregationshemmern. Anaesthesist 2007; 56: 592-598
    CrossrefPubMedGoogle Scholar
  • 32 Abrahams MS, Aziz MF, Fu RF et al. Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth 2009; 102: 408-417
    CrossrefPubMedGoogle Scholar
  • 33 Neuburger M, Buttner J. Komplikationen bei peripherer Regionalanästhesie. Anaesthesist 2011; 60: 1014-1026
    CrossrefPubMedGoogle Scholar
  • 34 Österreichische Gesellschaft für Anästhesie Reanimation und Intensivmedizin. Richtlinien perioperative Gerinnung 2010
    PubMed
  • 35 Bristol-Myers Squibb. Fachinformation Eliquis® 2012
    PubMed
  • 36 Kreutz R. Pharmacodynamic and pharmacokinetic basics of rivaroxaban. Fundam Clin Pharmacol 2012; 26: 27-32
    CrossrefPubMedGoogle Scholar
  • 37 Bauersachs R, Gogarten W, Hach-Wunderle V et al. Perioperatives Management der Antikoagulation mit Rivaroxaban – Konsensus einer interdisziplinären Arbeitsgruppe. Klinikarzt 2012; 424-431
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Bayer Pharma. Fachinformation Xarelto® 2012
    PubMed
  • 39 Liew A, Douketis J. Perioperative management of patients who are receiving a novel oral anticoagulant. Intern Emerg Med 2013; 8: 477-484
    CrossrefPubMedGoogle Scholar
  • 40 Spannagl M, Bauersachs R, Debus ES et al. Therapie mit Dabigatran. Periinterventionelles Management und Interpretation von Gerinnungstests. Haemostaseologie 2012; 32: 294-305
    PubMedGoogle Scholar
  • 41 Douketis JD, Spyropoulos AC, Spencer FA et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis. Chest 2012; 141: e326S-e350S
    CrossrefPubMedGoogle Scholar
  • 42 Connolly G, Spyropoulos AC. Practical issues, limitations, and periprocedural management of the NOAC’s. J Thromb Thrombolysis 2013; 36: 212-222
    CrossrefPubMedGoogle Scholar
  • 43 Boehringer Ingelheim. Fachinformation Pradaxa® 2014
    PubMed
  • 44 Schellong SM, Haas S. Perioperative Thromboseprophylaxe – Neue orale Antikoagulantien und ihre Anwendung im Umfeld operativer Eingriffe. Anaesthesiol Intensivmed Notfallmed Schmerzther 2012; 47: 266-272
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120: 2954-2962
    CrossrefPubMedGoogle Scholar
  • 46 Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood 2012; 119: 3016-3023
    CrossrefPubMedGoogle Scholar
  • 47 Vilchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf 2014; 5: 8-20
    CrossrefPubMedGoogle Scholar
  • 48 AWMF. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Arbeitsgemeinschaften S3-Leitlinie zur Prophylaxe venöser Thromboembolien 2009
    PubMed
  • 49 Siegal D, Yudin J, Kaatz S et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630-1639
    CrossrefPubMedGoogle Scholar
  • 50 Gallego P, Apostolakis S, Lip GY. Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. Circulation 2012; 126: 1573-1576
    CrossrefPubMedGoogle Scholar
  • 51 Sie P, Samama CM, Godier A et al. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Arch Cardio Dis 2011; 104: 669-676
    PubMedGoogle Scholar
  • 52 Schlitt A, Jambor C, Spannagl M et al. Perioperativer Umgang mit Antikoagulanzien und Thrombozytenaggregationshemmern. Dtsch Ärztebl Int 2013; 110: 525-532
    PubMedGoogle Scholar
  • 53 Lahtela H, Rubboli A, Schlitt A et al. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Circ J 2012; 76: 1363-1368
    CrossrefPubMedGoogle Scholar
  • 54 Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. EHJ 2012; 33: 2719-2747
    CrossrefPubMedGoogle Scholar
  • 55 Healey JS, Eikelboom J, Douketis J et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012; 126: 343-348
    CrossrefPubMedGoogle Scholar
  • 56 Wysokinski WE, McBane RD. Periprocedural bridging management of anticoagulation. Circulation 2012; 126: 486-490
    CrossrefPubMedGoogle Scholar